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China need to become aware of R. japonica disease presen-
tation, so they can administer the appropriate treatment to 
patients with suspected R. japonica infections.
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Burkholderia lata was isolated from 8 intensive care pa-
tients at 2 tertiary hospitals in Australia. Whole-genome 
sequencing demonstrated that clinical and environmental 
isolates originated from a batch of contaminated commer-
cial chlorhexidine mouthwash. Genomic analysis identified 
efflux pump–encoding genes as potential facilitators of bac-
terial persistence within this biocide.
Burkholderia contaminans and B. lata together formgroup K of the B. cepacia complex (Bcc). These pre-
dominantly environmental species are a major cause of 
pharmaceutical contamination and have been linked to 
multiple instances of associated opportunistic infection (1). 
Although both species are capable of causing serious infec-
tions in humans (2,3), only B. contaminans has been associ-
ated with infection outbreaks (3,4). We report a healthcare-
associated B. lata infection outbreak occurring in intensive 
care units (ICUs) in 2 tertiary hospitals in Australia.
During May–June 2016, bacterial contamination of 
chlorhexidine mouthwash (0.2% mg/mL) was associated 
with an interjurisdictional outbreak in New South Wales 
and South Australia. Bcc isolates were obtained from blood 
and tracheal aspirates from 6 ICU patients in hospital A 
(South Australia) (sample information and isolation pro-
tocols detailed in the online Technical Appendix, https://
wwwnc.cdc.gov/EID/article/24/11/17-1929-Techapp1.
pdf). An investigation by the hospital’s infection and pre-
vention control team noted discoloration of a commercial 
chlorhexidine mouthwash. Bcc isolates were cultured from 
all 5 tested bottles from the discolored batch but not from 
11 bottles tested from 4 other batches. Isolates were further 
obtained from the surfaces of hand basins in 3 separate ICU 
rooms, where bottles of mouthwash from the contaminated 
batch were in use. Separately, a Bcc isolate was obtained 
from the sputum of an ICU patient in hospital B (New 
South Wales), where the same batch of mouthwash was in 
use. After a nationwide recall of the contaminated mouth-
wash batch, no further cases were reported. 
The genomes of 15 Bcc isolates from the 2 hospitals 
were sequenced (online Technical Appendix). A closed ge-
nome of isolate A05 was generated as a reference, consist-
ing of 3 circular chromosomes of 3.93, 3.71, and 1.15 Mbp 
(National Center for Biotechnology Information BioPro-
ject accession no. PRJNA419071).
Genome analysis identified an Australasian sublineage 
of B. lata as the cause of the outbreak. Specifically, all iso-
lates were sequence type 103 (ST103), which sits within a 
subclade of B. lata isolates from Australia and New Zea-
land (online Technical Appendix Figure 1). Two isolates 
from hand basins (A07 and A08) and 1 from a hospital 
bench (A10) were of unknown sequence type.
Single-nucleotide polymorphism (SNP)–based phylo-
genetic analysis identified the outbreak strain as a distinct 
clonal lineage (0–1 SNPs) within the group K clade (Fig-
ure), separated from other members of the group by a min-
imum of 167,662 SNPs. SNP variation within the clonal 
sublineage ranged from 0 to 2 SNPs across isolates from 
contaminated mouthwash bottles and patients. A single 
SNP distinguished isolates from patient 4 in room 21 (A04) 
and the hand basin in the same room (A08) (collected 2 
days apart). Three of the taxa isolated from the hospital en-
vironment (A07, A08, and A10) had substantial SNP varia-
tions compared with contaminated mouthwash and patient 
isolates (an average of 191,893 SNPs for A07, 655 SNPs 
for A08, and 1,408 SNPs for A10).
Differences of 0–1 SNPs between isolates from mouth-
wash in the 2 hospitals, including from unopened bottles, 
strongly suggests contamination during the manufacturing 
process. After several previous incidents of contamination 
of cosmetic, toiletry, and pharmaceutical products by mem-
bers of Bcc, the US Food and Drug Administration com-
mented that these bacteria very likely are introduced into 
the manufacturing processes through contaminated water 
(https://www.fda.gov/Drugs/DrugSafety/ucm559508.htm). 
Direct patient-to-patient transmission of B. lata would ap-
pear unlikely in this instance, given the use of individual 
ICU rooms with nonshared facilities and incomplete over-
lap in periods of care.
Chlorhexidine mouthwash is perhaps a surprising 
source of B. lata infection, given its potent biocidal prop-
erties. However, Bcc species have been isolated previ-
ously from 0.02% chlorhexidine gluconate (in irrigation 
apparatuses used for vaginal douching) and from 0.05% 
preparations (used for storage of suction catheters) (5). 
The ability of B. lata to remain viable in chlorhexidine 
appears to be a result of a combination of efflux pump 
activity, biofilm formation, and cell wall impermeability 
(1,6,7). These mechanisms probably also contribute to 
the common inefficacy of combination antibiotic therapy 
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Figure. Phylogenetic analysis of isolates implicated in an outbreak Burkholderia lata infection from intrinsically contaminated 
chlorhexidine mouthwash, Australia, 2016. The maximum-likelihood tree is constructed from core genome single-nucleotide 
polymorphism alignments (N = 512,480) of the outbreak genomes, bootstrapped 1,000 times, and archival genomes from B. cepacia 
complex group K, relative to the reference genome B. lata A05 (identified by an asterisk). B. metallica was included as a comparator.
in the treatment of associated infections (8). Prolonged 
exposure to microbiocides, including chlorhexidine, has 
been shown to result in a stable increase in the expression 
of antibiotic-resistance mechanisms (1,6), and elevated 
chlorhexidine resistance has been reported in multidrug-
resistant strains of B. cenocepacia from cystic fibro-
sis patients (9). Three resistance-nodulation-division 
(RND) efflux pump genes (RND3, RND4, and RND9) 
have been shown to be essential for chlorhexidine toler-
ance in B. cenocepacia (9). Examination of the complete 
genome of B. lata isolate A05 revealed the presence of 
RND3, RND4, and RND9 in each strain (>94% sequence 
identity) (online Technical Appendix Figure 2).
B. contaminans is the cause of widespread pharma-
ceutical product contamination, and infection outbreaks 
by this species are well-documented (3,10). Our findings 
suggest that the other member of Bcc group K, B. lata, 
also represents an important opportunistic pathogen of 
relevance to infection control, particularly given its in-
trinsic biocide tolerance.
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We estimated the latent tuberculosis infection (LTBI) rate 
for foreign-born students at Keio University, Tokyo, Japan, 
using an interferon-γ release assay. The LTBI rate for stu-
dents from countries with estimated tuberculosis incidence 
>100 cases/100,000 persons was high (10.0%). Universi-
ties should screen for LTBI in students from countries with 
high tuberculosis incidence.
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